Closed System Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.

The global Closed System Transfer Device market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Closed System Transfer Device volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Closed System Transfer Device market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Closed System Transfer Device Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices

Segment by Application
Hospital
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
Sweden
France
Finland
Spain
Asia-Pacific
China
Japan
India
Southeast Asia
Australia
Latin America
Mexico
Middle East & Africa
Turkey
Saudi Arabia

By Company
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical
B. Braun